Visual and coenesthetic hallucinations associated with modafinil

Journal of Clinical Psychopharmacology

Volumn 28, Issue 2, 2008, Pages 251-252

  Oulis, Panagiotis ^a   Kouzoupis, Anastasios V ^a   Kontoangelos, Konstantinos ^a   Pachou, Elli ^a   Masdrakis, Vasilios G ^a   Soldatos, Constantin R ^a  

^a NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

MODAFINIL; VENLAFAXINE;

ADD ON THERAPY; ADULT; AGITATION; ANAMNESIS; CASE REPORT; DAYTIME SOMNOLENCE; DRUG DOSE TITRATION; DRUG WITHDRAWAL; FATIGUE; FEAR; FOLLOW UP; HUMAN; INSOMNIA; LETTER; MAJOR DEPRESSION; MALE; PRIORITY JOURNAL; SIDE EFFECT; VISUAL HALLUCINATION;

BENZHYDRYL COMPOUNDS; CENTRAL NERVOUS SYSTEM STIMULANTS; DEPRESSIVE DISORDER, MAJOR; HALLUCINATIONS; HUMANS; MALE; MIDDLE AGED;

EID: 40949083990     PISSN: 02710749     EISSN: None     Source Type: Journal    
DOI: 10.1097/JCP.0b013e318167464d     Document Type: Letter

References (10)

1. Keating GM, Raffin MJ. Modafinil. A review of its use in excessive sleepiness associated with obstructive sleep apnea/hypopnea syndrome and shift work sleep disorder. CNS Drugs. 2005;19:785-803.
2. Tuner DC, Clark L, Pomatol-Clotet E, et al. Modafinil improves cognition and attentional set shifting in patients with chronic schizophrenia. Neuropsychopharmacology. 2004;29:1363-1373.
3. Orr K, Taylor D. Psychostimulants in the treatment of depression: a review of the evidence. CNS Drugs. 2007;21:239-257.
4. Pierre JM, Peloian JH, Witsching DA, et al. A randomized, double-blind, placebo-controlled trial of modafinil for negative symptoms in schizophrenia. J Clin Psychiatry. 2007;68:705-710.
5. Naranjo CA, Busto U, Sellers EM, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981;30:239-245.
6. Narendran R, Young CM, Valenti AM, et al. Is psychosis exacerbated by modafinil? Arch Gen Psychiatry. 2002;59:292-293.
7. Mariani JJ, Hart CL. Psychosis associated with modafinil and shift work. Am J Psychiatry. 2005;162:1983. (letter).
8. Sery S, Rosenthal MH, Alvir J, et al. Double blind, placebo-controlled study of modafinil for fatigue and cognition in schizophrenic patients treated with psychotropic medications. J Clin Psychiatry. 2005;66:839-843.
9. 3H]dopamine release and alters the subjective properties of stimulants. Eur J of Pharmacol. 2007. doi:10.1016/j.ejphar.2007.03.044.
10. Murillo-Rodriguez, Haro R, Palomero-Rivero M, et al. Modafinil enhances extracellular levels of dopamine in the nucleus accumbens and increases wakefulness in rats. Behav Brain Res. 2007;176:353-357.